Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design

Drug Delivery

Volumn 19, Issue 2, 2012, Pages 90-101

  Liu, Yu ^a   Yoo, Sun Dong ^c   Li, Li ^a   Fang, Liang ^b   Wen, Ziyi ^b   Li, Tiefu ^b  

^a LIAONING UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Sungkyunkwan University   (South Korea)

Author keywords

Boanmycin; DSC; Liposomes; NMR; Spherical symmetric design; Tissue distribution

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BLEOMYCIN A6; CHOLESTEROL; LIPID; LIPOSOME; PHOSPHATIDYLCHOLINE; QIANGSHEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANISOTROPY; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SOYBEAN; TEMPERATURE;

ANIMALS; APOPTOSIS; BLEOMYCIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DRUG STABILITY; FEMALE; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPID BILAYERS; LIPIDS; LIPOSOMES; MALE; MICE; NONLINEAR DYNAMICS; PHOSPHATIDYLCHOLINES; RESEARCH DESIGN; TISSUE DISTRIBUTION;

EID: 84863039967     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.649217     Document Type: Article

References (34)

1. Deng, Y.C., Zhen, Y.S., Zheng, S., Xue, Y.C., 2001. Activity of boanmycin against colorectal cancer. World J. Gastroenterol. 7, 93-97. (Pubitemid 32170905)
2. El Maghraby, G.M.,Williams, A.C., Barry, B.W., 2001. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J. Pharm. Pharmacol. 53, 1069-1077. (Pubitemid 32754937)
3. El Maghraby, G.M., Williams, A.C., Barry, B.W., 2005. Drug interaction and location in liposomes: correlation with polar surface areas. Int. J. Pharm. 292, 179-185. (Pubitemid 40255799)
4. Gabizon, A., Martin, F., 1997. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 54, 15-21. (Pubitemid 27487791)
5. Guan, Z., Ye, H., Yang, X.P., Ding, J.H., Liang, Y.J., Gong, J., 2000. Boanmycin induces apoptosis in human nasopharyngeal cancer cells. Ai Zheng 19, 293-295.
6. Heimburg, T., 1998. Mechanical aspects of membrane thermodynamics. Estimation of the mechanical properties of lipid membranes close to the chain melting transition from calorimetry. Biochim. Biophys. Acta 1415, 147-162. (Pubitemid 29050769)
7. Jiang, J., Yang, S.J., Wang, J.C., Yang, L.J., Xu, Z.Z., Yang, T., Liu, X.Y., Zhang, Q., 2010. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. Eur. J. Pharm. Biopharm. 76, 170-178.
8. Liu, X.J., Li, Y., Zhen, Y.S., 2001. Inhibitory effect of boanmycin on the growth of colon carcinoma 26 and hepatic metastasis in mice. Yao Xue Xue Bao 36, 14-18.
9. Liu, Y., Yoo, S.D., Fang, L., Jin, X., Li, L., Ren, Y.J., Yao, C.S., Li, T.F., 2009. Determination of boanmycin in pharmaceutical preparations by a simple and rapid ion-pair LC method. Chromatographia 70, 643-646.
10. Liu, Y., Yoo, S. D., Fang, L., Jin, X., Li, L., Li, T.F., 2010. Ion-pair LC-UV method for the determination of boanmycin in mouse plasma and its application to a pharmacokinetic study. Chromatographia 72, 357-359.
11. Ma, J.L., Feng, F.Y., Zhou, L.Q., Sun, Y., 2005
12. Martin, F.J., 1998. Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin). In: Lasic, D.D., Papahadjopoulos, D. (Eds.), Medical Applications of Liposomes. Elsevier Science, New York, pp. 635-688.
13. Matsingou, C., Demetzos, C., 2007. Calorimetric study on the induction of interdigitated phase in hydrated DPPC bilayers by bioactive labdanes and correlation to their liposome stability: The role of chemical structure. Chem. Phys. Lipids 145, 45-62. (Pubitemid 44889207)
14. Mcelhaney, R.N., 1982. The use of differential scanning calorimetry and differential thermal-analysis in studies of model and biological-membranes. Chem. Phys. Lipids 30, 229-259.
15. McMullen, T.P., McElhaney, R.N., 1995. New aspects of the interaction of cholesterol with dipalmitoylphosphatidylcholine bilayers as revealed by high-sensitivity differential scanning calorimetry. Biochim. Biophys. Acta 1234, 90-98.
16. Mohanraj, V.J., Barnes, T.J., Prestidge, C.A., 2010. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins, Int. J. Pharm. 15, 285-293.
17. Negishi, Y., Matsuo K., Endo-Takahashi, Y., Suzuki, K., Matsuki, Y., Takagi, N., Suzuki, R., Maruyama, K., Aramaki, Y., 2010. Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure. Pharm. Res. Online first.
18. Papahadjopoulos, D., 1999. Steric stabilization an overview. In: Janoff, A.S. (Ed.), Liposomes Rational Design. Marcel Dekker, New York, pp. 1-12.
19. Peng, Z., Zhen, Y.S., 1991. Experimental studies on the antitumor activity of monoclonal antibody-bleomycin A6 conjugate against human liver cancer. Yao Xue Xue Bao 26, 331-335.
20. Presti, F.T., Pace, R.J., Chan, S.I., 1982. Cholesterolphospholipid interactions in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domain. Biochemistry 21, 3831-3835. (Pubitemid 13230951)
21. Rudra, A., Deepa, R.M., Ghosh, M.K., Ghosh, S., Mukherjee, B., 2010. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. Int. J. Nanomedicine 21, 811-823.
22. Sharma, A., Straubinger, R.M., 1994. Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm. Res. 11, 889-896. (Pubitemid 24210627)
23. Skalko, N., Brandl, M., BecirevicLacan, M., FilipovicGrcic, J., Jalsenjak, I., 1996. Liposomes with nifedipine and nifedipine-cyclodextrin complex: calorimetrical and plasma stability comparison. Eur. J. Pharm. Sci. 4, 359-366. (Pubitemid 26392432)
24. Snyder, B, Freire, E. 1980. Compositional domain structure in phosphatidylcholine-cholesterol and sphingomyelin-cholesterol bilayers. Proc. Natl. Acad. Sci. USA 77, 4055-4059. (Pubitemid 10022547)
25. Szoka, Jr., F., Papahadjopoulos, D., 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 75, 4194-4198. (Pubitemid 9025976)
26. Takayama, K., Imaizumi, H., Nambu, N., Nagai, T., 1985. Mathematical optimization of formulation of indomethacin/ polyvinylpolypyrrolidone/methyl cellulose solid dispersions by the sequential unconstrained minimization technique. Chem. Pharm. Bull. (Tokyo). 33, 292-300. (Pubitemid 15130857)
27. Tang, H., Yang, X.P., 2002. Effect of boanmycin on apoptosis and cell cycle of human esophageal cancer (Eca-109) cells. Ai Zheng 21, 855-859.
28. Umezawa, H., Takita, T., 1980. The bleomycins: Antitumor copperbinding antibiotics. Structure & Bonding, 40, 73-99.
29. Vaage, J., Donovan, D., Loftus, T., Uster, P., Working, P., 1995. Prophylaxis and therapy of mouse mammary carcinomas with doxorubicin and vincristine encapsulated in sterically stabilized liposomes. Eur. J. Cancer. 31A, 367-372.
30. Vaage, J., Donovan, D., Uster, P., Working, P., 1997. Tumor uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoM.A. Br. J. Cancer 75, 482-486. (Pubitemid 27085286)
31. Vaage, J., Donovan, D., Wipff, E., Abra, R., Colbern, G., Uster, P., Working, P., 1999. Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in longcirculating pegylated stealth liposomes. Int. J. Cancer 80, 134-137. (Pubitemid 28559789)
32. Wu, J., Lee, A., Lu, Y., Lee, R.J., 2007. Vascular targeting of doxorubicin using cationic liposomes. Int. J. Pharm. 337, 329-335. (Pubitemid 46756051)
33. Yang, Z., Yang, M., Xiahou, G., Peng, J., Zhang, J., 2009. Targeted delivery of insulin-modified immunoliposomes in vivo. J. Liposome Res. 19, 116-121.
34. Zhang H., Y., Xie Z., Li D.,D., 2001. Study on the effect of boanmycin against human-hepatoma BEL-7402 cells and its mechanism in molecular level. Chinese Journal of New Drugs. 10, 749-752.